AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

ITT Engineered Valves Introduces Ultra-Compact EnviZion® Valve Product Line for BioPharm Industry

November 18, 2019

SENECA FALLS, N.Y.--(BUSINESS WIRE)--Nov 18, 2019--

ITT Inc.’s (NYSE: ITT) Engineered Valves brand is proud to announce the latest addition to the extensive EnviZion valve product line. The new BioviZion fractional size valve includes the breakthrough technology of the EnviZion valve platform in a compact package for 1/4-1/2” applications, with features that provide a more reliable and less costly valve to operate and maintain.

“The unique EnviZion design has set a new standard for valves in the BioPharm industry,” said Dave Loula, Global Product Director for ITT Engineered Valves. “We have incorporated the same patented technology into a fractional size valve and added new features to overcome challenges related to dimensional limitations. This provides manufacturers with improved performance and reliablility for critical sampling and low flow installations.”

Key features of the new valve option include:

The EnviZion valve platform offers a more streamlined installation and maintenance process, delivering less downtime, longer preventative maintenance cycles and greater production capacity for manufacturers. Assembled with a simple mount and turn motion, the EnviZion valve is maintained in approximately three minutes without using any special tools or difficult torquing procedures. The valve’s 360° active seal protection provides leak-free operation, helping eliminate the risk of contamination and the need to re-torque after thermal cycling.

Visit www.engvalves.com/en-US/Products/BioviZion-valve/ for more information.

About ITT

ITT is a diversified leading manufacturer of highly engineered critical components and customized technology solutions for the transportation, industrial, and oil and gas markets. Building on its heritage of innovation, ITT partners with its customers to deliver enduring solutions to the key industries that underpin our modern way of life. ITT is headquartered in White Plains, N.Y., with employees in more than 35 countries and sales in approximately 125 countries. The company generated 2018 revenues of $2.75 billion. For more information, visit www.itt.com.

ITT’s Industrial Process business is a global manufacturer of industrial pumps, valves, monitoring and control systems, and aftermarket services for the biopharmaceutical, food and beverage, chemical, oil and gas, mining, pulp and paper, power and general industrial markets through leading brands including Goulds Pumps ( www.gouldspumps.com ), Rheinhütte ( www.rheinhuette.de ), Bornemann ( www.bornemann.com ), PRO Services ( www.ittproservices.com ), Engineered Valves ( www.engvalves.com ) and C’treat ( www.ctreat.com ).

View source version on businesswire.com:https://www.businesswire.com/news/home/20191118005096/en/

CONTACT: Investors:

Emmanuel Caprais

+1 (914) 641-2030

emmanuel.caprais@itt.com

Media:

Laurent Lawrence

+1 (914) 304-1809

laurent.lawrence@itt.com

Trade Media:

Gregg Dinino

+1 (585) 340-9407

gregg.dinino@partnersandnapier.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: ENGINEERING HEALTH TECHNOLOGY MANUFACTURING PHARMACEUTICAL HARDWARE BIOTECHNOLOGY

SOURCE: ITT Inc.

Copyright Business Wire 2019.

PUB: 11/18/2019 06:45 AM/DISC: 11/18/2019 06:45 AM

http://www.businesswire.com/news/home/20191118005096/en